 Description |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AATK | --- | Apoptosis-associated tyrosine kinase | |||||||||||||||
| ACVR1 | Activin receptor type-1 Precursor (EC 2.7.11.30)(Activin receptor type I)(ACTR-I)(Serine/threonine-protein kinase receptor R1)(SKR1)(Activin receptor-like kinase 2)(ALK-2)(TGF-B superfamily receptor type I)(TSR-I) | ||||||||||||||||
| ADCK1 | --- | Uncharacterized aarF domain-containing protein kinase 1 Precursor (EC 2.7.11.-) | |||||||||||||||
| ADCK5 | AarF domain containing kinase 5 | ||||||||||||||||
| AKT1 | V-akt murine thymoma viral oncogene homolog 1 | ||||||||||||||||
| AKT3 | V-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | ||||||||||||||||
| ALK | Anaplastic lymphoma receptor tyrosine kinase | ||||||||||||||||
| ARAF | --- | --- | A-Raf proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (A- raf-1) (Proto-oncogene Pks) | ||||||||||||||
| ATM | --- | --- | Serine-protein kinase ATM (EC 2.7.11.1)(Ataxia telangiectasia mutated)(A-T, mutated) | ||||||||||||||
| AURKA | Aurora kinase A | ||||||||||||||||
| AURKB | Serine/threonine-protein kinase 12 (EC 2.7.11.1)(Aurora-B)(Aurora- and Ipl1-like midbody-associated protein 1)(AIM-1)(Aurora/IPL1-related kinase 2)(Aurora-related kinase 2)(STK-1) | ||||||||||||||||
| AURKC | Aurora kinase C | ||||||||||||||||
| AXL | AXL receptor tyrosine kinase | ||||||||||||||||
| BLK | Tyrosine-protein kinase BLK (EC 2.7.10.2)(B lymphocyte kinase)(p55-BLK) | ||||||||||||||||
| BMPR1A | Bone morphogenetic protein receptor, type IA | ||||||||||||||||
| BMPR1B | Bone morphogenetic protein receptor type-1B Precursor (EC 2.7.11.30)(CDw293 antigen) | ||||||||||||||||
| BMX | BMX non-receptor tyrosine kinase | ||||||||||||||||
| CAMK1D | Calcium/calmodulin-dependent protein kinase ID | ||||||||||||||||
| CAMK1G | --- | Calcium/calmodulin-dependent protein kinase IG | |||||||||||||||
| CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha | ||||||||||||||||
| CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | ||||||||||||||||
| CAMK2D | Calcium/calmodulin-dependent protein kinase II delta | ||||||||||||||||
| CAMK4 | Calcium/calmodulin-dependent protein kinase IV | ||||||||||||||||
| CDC2L6 | Cell division cycle 2-like 6 (CDK8-like) | ||||||||||||||||
| CDC42BPB | CDC42 binding protein kinase beta (DMPK-like) | ||||||||||||||||
| CDK10 | Cyclin-dependent kinase 10 | ||||||||||||||||
| CDK2 | Cyclin-dependent kinase 2 | ||||||||||||||||
| CDK3 | Cell division protein kinase 3 (EC 2.7.11.22) | ||||||||||||||||
| CDK4 | Cell division protein kinase 4 (EC 2.7.11.22)(Cyclin-dependent kinase 4)(PSK-J3) | ||||||||||||||||
| CDK5 | Cyclin-dependent kinase 5 | ||||||||||||||||
| CDK6 | Cyclin-dependent kinase 6 | ||||||||||||||||
| CDK7 | Cyclin-dependent kinase 7 | ||||||||||||||||
| CDKL5 | Cyclin-dependent kinase-like 5 | ||||||||||||||||
| CHEK1 | Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) | ||||||||||||||||
| CIT | Citron (rho-interacting, serine/threonine kinase 21) | ||||||||||||||||
| CLK1 | Dual specificity protein kinase CLK1 (EC 2.7.12.1)(CDC-like kinase 1) | ||||||||||||||||
| CLK2 | CDC-like kinase 2 | ||||||||||||||||
| CRKRS | Cdc2-related kinase, arginine/serine-rich | ||||||||||||||||
| CSF1R | Colony stimulating factor 1 receptor | ||||||||||||||||
| CSK | Tyrosine-protein kinase CSK (EC 2.7.10.2)(C-SRC kinase)(Protein-tyrosine kinase CYL) | ||||||||||||||||
| CSNK1A1L | Casein kinase 1, alpha 1-like | ||||||||||||||||
| CSNK1E | Casein kinase 1, epsilon | ||||||||||||||||
| CSNK1G1 | Casein kinase 1, gamma 1 | ||||||||||||||||
| CSNK1G2 | Casein kinase 1, gamma 2 | ||||||||||||||||
| CSNK2A2 | Casein kinase 2, alpha prime polypeptide | ||||||||||||||||
| DCLK1 | Doublecortin-like kinase 1 | ||||||||||||||||
| DCLK2 | Doublecortin-like kinase 2 | ||||||||||||||||
| DDR1 | Discoidin domain receptor tyrosine kinase 1 | ||||||||||||||||
| DYRK1B | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | ||||||||||||||||
| DYRK2 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) | ||||||||||||||||
| DYRK4 | Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | ||||||||||||||||
| EEF2K | Eukaryotic elongation factor-2 kinase | ||||||||||||||||
| EGFR | Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | ||||||||||||||||
| EIF2AK1 | Eukaryotic translation initiation factor 2-alpha kinase 1 | ||||||||||||||||
| EIF2AK4 | Eukaryotic translation initiation factor 2 alpha kinase 4 | ||||||||||||||||
| EPHA3 | EPH receptor A3 | ||||||||||||||||
| EPHA5 | EPH receptor A5 | ||||||||||||||||
| EPHA7 | EPH receptor A7 | ||||||||||||||||
| EPHA8 | EPH receptor A8 | ||||||||||||||||
| EPHB2 | EPH receptor B2 | ||||||||||||||||
| EPHB6 | EPH receptor B6 | ||||||||||||||||
| ERBB2 | --- | Receptor tyrosine-protein kinase erbB-2 Precursor (EC 2.7.10.1)(p185erbB2)(C-erbB-2)(NEU proto-oncogene)(Tyrosine kinase-type cell surface receptor HER2)(MLN 19)(CD340 antigen) | |||||||||||||||
| ERN1 | Endoplasmic reticulum to nucleus signaling 1 | ||||||||||||||||
| FGFR1 | --- | --- | Basic fibroblast growth factor receptor 1 precursor (EC 2.7.10.1) (FGFR-1) (bFGF-R) (Fms-like tyrosine kinase 2) (c-fgr) (CD331 antigen) | ||||||||||||||
| FGFR3 | --- | Fibroblast growth factor receptor 3 | |||||||||||||||
| FLT1 | --- | --- | Fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | ||||||||||||||
| FRK | Fyn-related kinase | ||||||||||||||||
| FYN | FYN oncogene related to SRC, FGR, YES | ||||||||||||||||
| GRK6 | G protein-coupled receptor kinase 6 (EC 2.7.11.16)(G protein-coupled receptor kinase GRK6) | ||||||||||||||||
| GRK7 | G protein-coupled receptor kinase 7 Precursor (EC 2.7.11.16)(G protein-coupled receptor kinase GRK7) | ||||||||||||||||
| GSK3B | Glycogen synthase kinase 3 beta | ||||||||||||||||
| GUCY2D | Guanylate cyclase 2D, membrane (retina-specific) | ||||||||||||||||
| HCN2 | Hyperpolarization activated cyclic nucleotide-gated potassium channel 2 | ||||||||||||||||
| HIPK3 | Homeodomain interacting protein kinase 3 | ||||||||||||||||
| ICK | Intestinal cell (MAK-like) kinase | ||||||||||||||||
| IGF1R | Insulin-like growth factor 1 receptor | ||||||||||||||||
| IKBKB | Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta)(IkBKB)(IKK-beta)(IKK-B)(EC 2.7.11.10)(I-kappa-B kinase 2)(IKK2)(Nuclear factor NF-kappa-B inhibitor kinase beta)(NFKBIKB) | ||||||||||||||||
| ILK | Integrin-linked kinase | ||||||||||||||||
| IRAK1 | Interleukin-1 receptor-associated kinase 1 | ||||||||||||||||
| ITK | --- | --- | Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2)(T-cell-specific kinase)(Tyrosine-protein kinase Lyk)(Kinase EMT) | ||||||||||||||
| KALRN | Kalirin, RhoGEF kinase | ||||||||||||||||
| KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | ||||||||||||||||
| LCK | Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2)(Lymphocyte cell-specific protein-tyrosine kinase)(p56-LCK)(LSK)(T cell-specific protein-tyrosine kinase) | ||||||||||||||||
| LIMK1 | LIM domain kinase 1 | ||||||||||||||||
| LIMK2 | --- | --- | LIM domain kinase 2 (LIMK-2)(EC 2.7.11.1) | ||||||||||||||
| LMTK2 | Lemur tyrosine kinase 2 | ||||||||||||||||
| LMTK3 | --- | Lemur tyrosine kinase 3 | |||||||||||||||
| LYN | Tyrosine-protein kinase Lyn (EC 2.7.10.2) | ||||||||||||||||
| MAK | Serine/threonine-protein kinase MAK (EC 2.7.11.22)(Male germ cell-associated kinase) | ||||||||||||||||
| MAP2K1 | --- | Mitogen-activated protein kinase kinase 1 | |||||||||||||||
| MAP2K2 | Mitogen-activated protein kinase kinase 2 | ||||||||||||||||
| MAP2K3 | Mitogen-activated protein kinase kinase 3 | ||||||||||||||||
| MAP2K7 | Mitogen-activated protein kinase kinase 7 | ||||||||||||||||
| MAP3K10 | --- | --- | Mitogen-activated protein kinase kinase kinase 10 (EC 2.7.11.25)(Mixed lineage kinase 2)(Protein kinase MST) | ||||||||||||||
| MAP3K3 | Mitogen-activated protein kinase kinase kinase 3 | ||||||||||||||||
| MAP3K4 | --- | --- | Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) (MAP three kinase 1) | ||||||||||||||
| MAP3K6 | --- | --- | Mitogen-activated protein kinase kinase kinase 6 (EC 2.7.11.25)(Apoptosis signal-regulating kinase 2) | ||||||||||||||
| MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | ||||||||||||||||
| MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 (EC 2.7.11.25)(COT proto-oncogene serine/threonine-protein kinase)(Cancer Osaka thyroid oncogene)(C-COT)(Tumor progression locus 2)(TPL-2) | ||||||||||||||||
| MAP4K1 | Mitogen-activated protein kinase kinase kinase kinase 1 | ||||||||||||||||